Pulte, E. D., Dmytrijuk, A., Nie, L., Goldberg, K. B., McKee, A. E., Farrell, A. T., & Pazdur, R. (2018). FDA Approval Summary: Lenalidomide as Maintenance Therapy After Autologous Stem Cell Transplant in Newly Diagnosed Multiple Myeloma. Oncologist.
Chicago-tyylinen lähdeviittausPulte, Elizabeth Dianne, Andrew Dmytrijuk, Lei Nie, Kirsten B. Goldberg, Amy E. McKee, Ann T. Farrell, ja Richard Pazdur. "FDA Approval Summary: Lenalidomide As Maintenance Therapy After Autologous Stem Cell Transplant in Newly Diagnosed Multiple Myeloma." Oncologist 2018.
MLA-viitePulte, Elizabeth Dianne, et al. "FDA Approval Summary: Lenalidomide As Maintenance Therapy After Autologous Stem Cell Transplant in Newly Diagnosed Multiple Myeloma." Oncologist 2018.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.